(877) 636-4978

Press Room

BioTime Division ESI BIO Launches New Responsive Design Website to the Scientific Community

ESI BIO’s website has been designed to provide the ultimate user-friendly experience whether on a desktop, tablet or mobile device. Allowing customers access to detailed product information and videos with the option to share information across all major social networking sites.

ALAMEDA, Calif., April 23, 2014 - BioTime, Inc. through its new research products division ESI BIO, today unveiled a new responsive design website,, which enriches the online research reagent shopping experience by delivering full content and functionality across all devices. As mobile and tablet use continues to skyrocket, the ESI BIO website allows consumers to access all of the website's features across multiple devices – desktop, tablet and smartphone.

BioTime's ESI BIO division and the new ESI BIO website, has been created to consolidate BioTime’s existing and new stem cell research products under one focused communication platform. ESI BIO's growing portfolio of research products includes the HyStem® hyaluronan-based hydrogels for 2- and 3D cell culture; the cGMP grade ESI human embryonic stem cell lines; the PureStem® embryonic progenitor cells, cell culture media and reagents, and ESI BIO's new portfolio of small molecules for stem cell research.

“With so many different devices and websites becoming available as part of the digital experience when making a purchasing decision, it was important that we build a site that offers a consistent, rich, online and mobile experience that meets consumers' expectations across all channels, and delivers a fast, seamless transaction. Our focus is on the customer experience,” said Jeffrey Janus, CEO at ESI BIO.

Market research has found that researchers are making purchasing decisions from searches, blogging, website research, and even online networking channels, in addition to traditional methods. As a result, the new site delivers a rich online experience that, today, consumers expect.

“This new website is a positive step forward for ESI BIO, and we are very proud that we were able to develop an enhanced online experience and set the foundation for both our future potential customers, as well as our valued existing ones. With our new website, we are able to release updates and enhancements faster with responsive design that minimally impact the customer,” added Janus.

The new website integrates customer account management tools with easy access to orders, copies of invoices, protocols, detailed product information, tagging, as well as product reviews that can be shared with others in the research community. The events section of the site highlights our strong commitment to the research community, placing a special focus on the upcoming International Society of Stem Cell Research event in Vancouver, in June of 2014, where ESI BIO will debut as an exhibitor.

ESI BIO -A Division of BioTime, Inc. (“ESI Cell International Pte Ltd.”) is a unique research reagent organization which markets and distributes human embryonic stem cell lines under conditions designed to be compliant with principles of current Good Manufacturing Practices (cGMP), making them suitable for use in clinical research and regenerative medicine. ESI BIO's portfolio also includes human embryonic progenitors, hyaluronan-based hydrogels, cell culture media, and kits for stem cell differentiation and reprogramming. ESI BIO's mission is to develop innovative research products that help translate scientific discoveries to the clinic. ESI BIO facilities are located in La Jolla and Alameda, California, with a third location in Singapore.

Media Contact:
ESI BIO - A Division of BioTime, Inc.
Jeffrey Janus, CEO
T: 510-521-3390 x376